Navigation Links
Lilly CEO: 'Are We Getting Our Money's Worth from Medical Innovation?'
Date:10/29/2010

DALLAS, Oct. 29 /PRNewswire/ -- In a speech to the Dallas Friday Group today, John C. Lechleiter, Ph.D., chairman, president and CEO of Eli Lilly and Company (NYSE: LLY), said that the value of medical innovation – particularly innovative medicines – far outstrips its cost.  Lechleiter marshaled data showing that medical innovation over the past century dramatically extended life spans, improved quality of life, and boosted productivity.

So far, the health care debate has revolved around access, quality, and cost—all of which need to be addressed, according to Lechleiter.  "But, we'll never improve in any of these areas – in fact, we risk going backwards – without taking into account two fundamental game-changers:  innovation and value."

By tackling diseases that had been impervious to medicine throughout human history, for example, medical innovation helped life expectancy rise by more than 30 years in the 20th century – an unprecedented 66 percent increase in life.  Thanks to medical technology – including innovative medicines, since 1975, Americans' death from heart disease has declined by nearly 60 percent, and five-year survival rates for cancer have expanded from 50 percent to nearly 70 percent.

"More than one million additional Americans would die of heart disease or stroke each year if the death rates were what they were 30 years ago," Lechleiter said, "and over 100,000 more people would be dying from cancer every year."

Lechleiter cited two economists who calculated that increasing life spans alone was worth as much as half the national GDP between 1970 and 1998.  Furthermore, medical innovation has also helped drive down the rates of functional disability, meaning people were living not just longer, but also better.

Lechleiter singled out innovative medicines as providing
'/>"/>

SOURCE Eli Lilly and Company
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. FDA Approves Lillys Osteoporosis Drug EVISTA(R) (raloxifene HCl) to Reduce The Risk of Invasive Breast Cancer in Two Populations of Postmenopausal Women
2. Lilly Files for European Approval of ALIMTA(R) (pemetrexed for injection) for First-Line Treatment of Non-Small Cell Lung Cancer
3. Lilly and Glenmark Pharmaceuticals Announce License Agreement
4. Lilly Receives NCQA Design Certification for Depression Care Management Program
5. JDRF and Lilly Partner to Fund Research to Identify Beta Cell Biomarkers
6. FDA Grants Priority Review for Daiichi Sankyo, Lilly Drug, prasugrel
7. Statement from Eli Lilly and Company: Response to Connecticut Attorney General News Release
8. Lilly and Transition Therapeutics Announce Licensing and Collaboration Agreement
9. Lilly Launches Its First Phase III Trial for Treatment of Alzheimers Disease
10. Daiichi Sankyo/Eli Lillys Effient and Astrazenecas Ticagrelor May Offer Advantages in the Treatment of Post-Myocardial Infarction
11. Lilly Submits Cymbalta(R) Supplemental New Drug Application for Chronic Pain to U.S. Food and Drug Administration
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2015)... , Aug. 27, 2015  BioElectronics Corporation (OTC Pink: BIEL), ... that three abstracts featuring the use of ActiPatch®, its ... 9 th Congress of the European Pain Federation ... September 2015. The Company will also be exhibiting ... Gianluca Bagnato , department clinical and experimental rheumatology ...
(Date:8/27/2015)... ATLANTA , August 27, 2015 ... Consortium convened in Boston on ... Consortium in an effort to more fully exploit the ... are applied to brain diseases. "As an ... has a responsibility to assume a leadership role - ...
(Date:8/27/2015)... FRANCISCO, Calif. , Aug. 27, 2015 /PRNewswire/ ... therapeutics for the treatment of cancer, today announced ... member of the company,s Board of Directors, has ... led immuno-oncology at Eli Lilly and AstraZeneca, and ... first FDA approved checkpoint inhibitor, at Bristol-Myers Squibb ...
Breaking Medicine Technology:BioElectronics Selected to Present its Pain Research and Devices at the European Pain Federation Conference 2New Elekta Consortium to Push Frontiers of Linear Accelerator-Based Stereotactic Radiation Therapy for the Brain 2New Elekta Consortium to Push Frontiers of Linear Accelerator-Based Stereotactic Radiation Therapy for the Brain 3Immuno-Oncology Veteran Rachel Humphrey, M.D., Joins CytomX as Chief Medical Officer 2Immuno-Oncology Veteran Rachel Humphrey, M.D., Joins CytomX as Chief Medical Officer 3
(Date:8/27/2015)... , ... August 27, 2015 , ... ... average annual cost to treat a patient with hemophilia is $175,000. Hemophilia is ... a cure and improving treatment. The RMHBDA exists to help raise funds for ...
(Date:8/27/2015)... CA (PRWEB) , ... August 27, 2015 , ... According ... and the American Heart Association have released new guidelines to educate doctors and patients ... last update to these particular guidelines came in 2007, so the new version is ...
(Date:8/27/2015)... ... August 27, 2015 , ... Allegheny General Hospital (AGH), part ... medical centers in the United States to receive international recognition for an advanced, ... Extracorporeal Life Support Organization (ELSO) , an international consortium of healthcare institutions dedicated ...
(Date:8/27/2015)... ... , ... About 10 percent of mothers experienced chronic, persistent ... more than 1,800 people, displacing hundreds of thousands and causing widespread damage estimated ... While most people don’t develop persistent depression after a major disaster like that, ...
(Date:8/27/2015)... Hills, CA (PRWEB) , ... August 27, 2015 ... ... Wearables & IoT Summit , scheduled for October 27-29, 2015 in San Jose, ... technology, the summit will primarily focus on the void that exists where battery ...
Breaking Medicine News(10 mins):Health News:Avitus Group Encourages Business & Employee Community Involvement; Senior Level Staff Leads Way With Support of Rocky Mountain Hemophilia & Bleeding Disorders Association 2Health News:Avitus Group Encourages Business & Employee Community Involvement; Senior Level Staff Leads Way With Support of Rocky Mountain Hemophilia & Bleeding Disorders Association 3Health News:Avitus Group Encourages Business & Employee Community Involvement; Senior Level Staff Leads Way With Support of Rocky Mountain Hemophilia & Bleeding Disorders Association 4Health News:Article on New Diabetic Care Guidelines Shines Brightly on Weight Loss Surgery, notes Beverly Hills Physicians 2Health News:Article on New Diabetic Care Guidelines Shines Brightly on Weight Loss Surgery, notes Beverly Hills Physicians 3Health News:International Organization Honors Allegheny General Hospital's Advanced Lifesaving Program for Cardiac and Respiratory Failure 2Health News:International Organization Honors Allegheny General Hospital's Advanced Lifesaving Program for Cardiac and Respiratory Failure 3Health News:International Organization Honors Allegheny General Hospital's Advanced Lifesaving Program for Cardiac and Respiratory Failure 4Health News:About 10 Percent of Mothers Experienced Depression Two Years After Hurricane Katrina, New Study Shows 2Health News:Infocast Hosting First Conference Dedicated to Powering Wearable Devices & the IoT 2
... of Women,s ... Ovarian Reserve, COLORADO ... announced it will be the first IVF center,in the region to ... an assessment of a woman,s egg supply by combining,multiple factors including ...
... claims companies knowingly misled consumers on the use of Zetia and ... ... Hagens Berman Sobol Shapiro filed,a proposed class-action lawsuit against Merck (NYSE: ... Vytorin alleging,Merck and Schering-Plough violated state consumer protection laws arising,from the sale ...
... Inc. (TSX: DDS,NASDAQ: DDSS) today announced that it ... iNova Pharmaceuticals (Australia) Pty Limited,for its once-daily tramadol ... of our once-daily tramadol product across,Europe and in ... as we,prepare for additional product launches in key ...
... 24 Weight Watchers,International, Inc. (NYSE: WTW ) ... year 2007 after the NYSE close on Thursday, February ... call on February 14th at,5:00 p.m. ET. During the ... Ann Sardini, Chief Financial Officer, will,discuss fourth quarter and ...
... with a camera could detect the earliest signs of cancer? ... in confined spaces. Such a device could find warning signs ... States. , A fundamentally new design has created a smaller ... to use than current technology. Its first use on a ...
... published today in the February issue of the ... of Biomaterials, Dalhousie University (Halifax, NS, Canada), and ... on Dentistry, denounces new Norwegian regulations governing the ... use of dental amalgam not only in Norway, ...
Cached Medicine News:Health News:Reproductive Medicine & Fertility Center is First in Southwest to Offer Pioneering Test of a Women's Biological Clock 2Health News:Reproductive Medicine & Fertility Center is First in Southwest to Offer Pioneering Test of a Women's Biological Clock 3Health News:Reproductive Medicine & Fertility Center is First in Southwest to Offer Pioneering Test of a Women's Biological Clock 4Health News:CORRECTED: Hagens Berman Sobol Shapiro Files Suit Against Merck and Schering-Plough 2Health News:CORRECTED: Hagens Berman Sobol Shapiro Files Suit Against Merck and Schering-Plough 3Health News:Labopharm enters into licensing and distribution agreement for once-daily tramadol in Australia with iNova 2Health News:Labopharm enters into licensing and distribution agreement for once-daily tramadol in Australia with iNova 3Health News:Weight Watchers Announces Fourth Quarter and Full Year 2007 Earnings Conference Call 2Health News:Camera in a pill offers cheaper, easier window on your insides 2Health News:Camera in a pill offers cheaper, easier window on your insides 3Health News:Materials expert denounces Norwegian ban on dental amalgam 2
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: